Intermittent Claudication Pipeline Assessment by Drug Target, MoA, RoA and More
Complete report on Intermittent Claudication pipeline spread across 64 pages, analyzing 5 companies, 6 drug profiles and supported with 20 tables and 12 figures is now available at http://www.rnrmarketresearch.com/intermittent-claudication-pipeline-review-h2-2015-market-report.html .
This report provides comprehensive information on the therapeutic development for Intermittent Claudication, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Intermittent Claudication and special features on late-stage and discontinued projects. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Global Markets Direct report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Companies mentioned in this Intermittent Claudication pipeline H2 2015 review report include Cytokinetics Inc., DNAVEC Corporation, Kowa Company Ltd., LTT Bio-Pharma Co. Ltd., Nuo Therapeutics Inc. and Pluristem Therapeutics Inc. Drug profiles discussed in this report are ALD-301, DVC1-0101, K-134, LT-0101, PLX-PAD and tirasemtiv. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Order a copy of Intermittent Claudication - Pipeline Review, H2 2015 market research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=419678 .
The report provides a snapshot of the global therapeutic landscape of Intermittent Claudication and reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities. The report reviews key players involved in the therapeutics development for Intermittent Claudication and enlists all their major and minor projects while summarizing all the dormant and discontinued pipeline projects. A review of the Intermittent Claudication products under development by companies and universities/research institutes based on information derived from company and industry-specific sources, pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages, a detailed assessment of monotherapy and combination therapy pipeline projects, coverage of the Intermittent Claudication pipeline on the basis of target, MoA, route of administration and molecule type, Latest news and deals relating related to pipeline products.
Explore more reports on therapeutics market at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics .
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Connect with Us:
G+ / Google Plus:https://plus.google.com/u/0/104156468549256253075/
Twitter:https://twitter.com/RnRMR
Facebook:https://www.facebook.com/pages/RnR-Market-Research/413488545356345
RSS / Feeds:http://www.rnrmarketresearch.com/feed
MediaContact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
